Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

b site is http://www.schering-plough.com.

SCHERING-PLOUGH CORPORATION

U.S. GAAP report for the fourth quarter ended December 31 (unaudited):

(Amounts in millions, except per share figures)

Fourth Quarter Full Year

2007 2006 2007 2006

Net sales 1/ $3,724 $2,650 $12,690 $10,594

Cost of sales 2/ 1,566 915 4,405 3,697

Selling, general

and administrative 1,634 1,250 5,468 4,718

Research and

development 3/ 855 631 2,926 2,188

Acquired in-process

research and

development 4/ 3,754 - 3,754 -

Other income, net 5/ (231) (46) (683) (135)

Special and acquisition

related charges 6/ 52 12 84 102

Equity income (566) (403) (2,049) (1,459)

(Loss)/income before

income taxes (3,340) 291 (1,215) 1,483

Income tax (benefit)/

expense (14) 87 258 362

Net (loss)/income

before cumulative

effect of a change

in accounting

principle $(3,326) $204 $(1,473) $ 1,121

Cumulative effect

of a change in

accounting principle,

net of tax 7/ - - - (22)

Net (loss)/income $(3,326) $204 $(1,473) $ 1,143

Preferred stock

dividends 38 22 118 86

Net (loss)/

income available

to common

shareholders $(3,364) $
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and TEL AVIV, Israel , May ... the "Company") (NYSE MKT: NSPR), a leader in embolic protection ... Company,s President and Chief Executive Officer, and Craig ... in the Benchmark Company, LLC One-on-One Investor Conference on Thursday ... Ave., Milwaukee, WI. The ...
(Date:5/24/2013)... 2013 Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients, ... Ph.D., the Company,s Vice President, Biology and ... Corporate Communications, will present an overview of Senomyx,s technology ... Eastern Time (7:25 a.m. Pacific Time) during the Citi ...
(Date:5/24/2013)... This market report summarizes the industry-wide ... out in May 2013. The full report provides ... responses for each question, its segmentation and the ... some interesting differences, particularly between Pharma, Biotech and ... developed to estimate the in house and outsourced ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... Lessons. Legacy.") features,Carnegie-Mellon Professor,s fight against pancreatic cancer and underscores, his call-to-action ... ... debuts on heels of Lustgarten Foundation,s limited online book offer,as seen on ABC ... ...
... 17 Spherix Incorporated,(Nasdaq: SPEX ) announced the ... Brown will be monitoring and overseeing all aspects of ... Naturlose(R) as a,treatment for Type 2 diabetes. The hiring ... with the Contract Research Organization (CRO),take over full control ...
... BioMed Realty Trust, Inc.,(NYSE: BMR ) today ... of common stock at $25.50 per share. The offering ... Gross proceeds from the offering will be,approximately $145.4 million. ... to repay a portion of the outstanding indebtedness under ...
Cached Biology Technology:The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring 'Last Lecturer' Dr. Randy Pausch 2Spherix Hires Key Employees 2BioMed Realty Trust Prices Public Offering of 5,700,000 Shares of Common Stock 2BioMed Realty Trust Prices Public Offering of 5,700,000 Shares of Common Stock 3
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
(Date:5/24/2013)... have focused among other factors on drugs that ... the accumulation of A-beta that causes the known plaques in ... of A-beta is APP. Alessia Soldano and Bassem Hassan (VIB/KU ... the fruit-fly version of APP in the brain ... "We have discovered that APPL ensures that brain cells form ...
(Date:5/24/2013)... from around the world today issued a stark warning ... one or two generations, the majority of the 9 ... handicap of severe pressure on fresh water, an absolutely ... This handicap will be self-inflicted and is, we believe, ... underlying problems led by mismanagement and sent a prescription ...
Breaking Biology News(10 mins):Please do try this at home 2A new strategy required in the search for Alzheimer's drugs? 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4
... An investigation of the genes that govern spore formation in ... role in determining which of the microbes sacrifice themselves for ... B. subtilis, a common soil bacteria, is a well-known survivor. ... in colonies or encase itself in a tough, protective spore ...
... -- European breast cancer specialists have taken a ... by bringing together world leaders in breast cancer research ... IMPAKT (IMProving cAre and Knowledge in Translational research). ... May 2009 in Brussels, Belgium, is designed to present ...
... Versions Support Development of Web-based Applications, Live Face ... ... Biometric Identification, VILNIUS, ... high-precision biometric identification,technologies, today announced the availability of two ...
Cached Biology News:Are sacrificial bacteria altruistic or just unlucky? 2Improving care and knowledge in translational research to fight breast cancer 2VeriFinger 6.0 SDK for Fingerprint Recognition and VeriLook 3.2 SDK for Facial Recognition are Now Available 2VeriFinger 6.0 SDK for Fingerprint Recognition and VeriLook 3.2 SDK for Facial Recognition are Now Available 3
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Spaced cover glasses to promote effective hybridization...
prototype Nco I...
... via cardiac puncture from 3 to 4 week ... is then centrifuged and frozen at -70C. The ... at 4C then stored at -70C. DIRECT SALES ... PEL-FREEZ COMPLEMENT, YOU CAN NOW BUY DIRECTLY FROM ...
Biology Products: